L-carnitine and acetyl-L-carnitine in human nerves from normal and diabetic subjects

Journal of the Peripheral Nervous System

Volumn 1, Issue 2, 1996, Pages 157-163

  Scarpini, Elio ^a,d   Doneda, Paola ^a   Pizzul, Silvia ^a   Chiodi, Piero ^b   Ramacci, Maria Teresa ^b   Baron, Pierluigi ^a   Conti, Giancarlo ^a   Sacilotto, Giorgio ^a   Arduini, Arduino ^c   Scarlato, Guglielmo ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Institute for Research on Senescence   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Acetyl L carnitine; Diabetic neuropathy; Ischemic neuropathy; L carnitine; Neuropathy; Peripheral nerve

Indexed keywords

ACETYLCARNITINE; CARNITINE;

ADULT; AGED; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; DIABETIC NEUROPATHY; FEMALE; HUMAN; ISCHEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; SCIATIC NERVE; TIBIAL NERVE;

ACETYLCARNITINE; ADULT; AGED; AGED, 80 AND OVER; CARNITINE; DIABETIC NEUROPATHIES; FEMALE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SCIATIC NERVE; TIBIAL NERVE;

EID: 18844418745     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Yagihashi S: Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes/Metab. Rev. 1995; 11:193-225.
2. Cameron NE, Cotter MA: The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes/Metab. Rev. 1994; 10:189-224.
3. Scarpini E, Bianchi R, Moggio M, Sciacco M, Fiori MG, Scarlato G: Decrease of nerve Na+, K+- ATPase activity in the pathogenesis of human diabetic neuropathy. J Neurol. Sci. 1993; 120:159-167.
4. 125I-nerve growth factor in rat ileal mesenteric nerves. Effect of streptozocin-diabetes. Diabetes 1985; 34:1230-1240.
5. Faradji V, Sotelo J: Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol. Scand. 1990; 81:402-406.
6. Hellweg R, Hartung H-D: Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J. Neurosci. Res. 1990; 26:258-267.
7. Calcutt NA, Muir D, Powell HC, Mizisin AP: Reduced ciliary neuronotrophic factor-like activity in nerves from diabetic or galactose-fed rats. Brain Res. 1992; 575:320-324.
8. Ordoñez G, Fernandez A, Perez R, Sotelo J: Low contents of nerve growth factor in serum and submaxillary gland of diabetic mice. A possible etiological element of diabetic neuropathy. J. Neurol. Sci. 1994; 121:163-166.
9. Rabinowe SL: Immunology of diabetic and polyglandular neuropathy. Diabetes/Metab. Rev. 1990; 6:169-188.
10. Cullum NA, Coleman JW, Casson IF, McLean WG: Antibodies to tubulin and microtubule-associated proteins. A study in diabetes mellitus, systemic lupus erythematosus, and rheumatoid arthritis. Mol. Chem. Neuropathol. 1991; 15:159-172.
11. Cameron NE, Cotter MA: Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: evidence from experimental studies. Diab. Med. 1993; 10:593-605.
12. Gold BG, Spencer PS: Neurotrophic function in normal nerve and in peripheral neuropathies. In. Neuroregeneratlon (Gorio A, ed). New York: Raven Press, 1993, pp. 101-122.
13. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA: Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 1994; 634:7-12.
14. Sango K, Verdes JM, Hikawa N, Horie H, Tanaka S, Inoue S, Sotelo JR, Takenaka T: Nerve growth factor (NGF) restores depletions of calcitonin gene-related peptide and substance P in sensory neurons from diabetic mice in vitro. J. Neurol. Sci. 1994; 126:1-5.
15. Pfeifer MA, Schumer MP: Clinical trials of diabetic neuropathy. Past, present, and future. Diabetes 1995; 44:1355-1361.
16. De Angelis C, Scarfò C, Falcinelli M, Perna E, Reda E, Ramacci MT, Angelucci L: Acetyl-L-carnitine prevents age-dependent structural alterations in rat peripheral nerves and promotes regeneration following sciatic nerve injury in young and senescent rats. Exp. Neurol. 1994; 128:103-114.
17. Pascale A, Milano S, Corsico N, Lucchi L, Battaini F, Arrigoni Martelli E, Trabucchi M, Govoni S: Protein kinase C activation and anti-amnesic effect of acetyl-L-carnitine: in vitro and in vivo studies. Eur. J. Pharmacol. 1994; 265:1-7.
18. Fernandez E, Pallini R, Tamburrini G, Lauretti L, Tancredi A, La Marca F: Effects of levo-acetylcarnitine on second motoneuron survival after axotomy. Neurol. Res. 1995; 17:373-376.
19. Onofrj M, Fulgente T, Melchionda D, Marchionni A, Tomasello F, Salpietro FM, Alafaci C, De Sanctis E, Pennisi G, Bella R, Ventura F, Morganti A: L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain. Int. J. Clin. Pharm. Res. 1995; 15:9-15.
20. Angelucci L, Ramacci MT, Taglialatela G, Hulsebosch C, Morgan B, Werrbach-Perez K, Perez-Polo R: Nerve growth factor binding in aged rat central nervous system: effect of acetyl-L-carnitine. J. Neurosci. Res. 1988; 20: 491-496.
21. Taglialatela G, Angelucci L, Ramacci MT, Werrbach-Perez K, Jackson GR, Perez-Polo JR: Acetyl-L-carnitine enhances the response of PC12 cells to nerve growth factor. Dev. Brain. Res. 1991; 59:221.
22. De Angelis C, Scarfò C, Falcinelli M, Perna E, Ramacci MT, Angelucci L: Age- and trauma-dependent modifications of neuromuscular junction and skeletal muscle structure in the rat. Effects of long-term treatment with Acetyl-L-Carnitine. Mech. Ageing Develop. 1995; 85:37-53.
23. Ido Y, McHowat J, Chang KC, Arrigoni Martelli E, Orfalian Z, Kilo C, Corr PB, Williamson JR: Neural dysfunction and metabolic imbalances in diabetic rats: prevention by acetyl-L-carnitine. Diabetes 1994; 43: 1469-1477.
24. Lowitt S, Malone JI, Salem AF, Korthals J, Benford S: Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metabolism 1995; 44: 677-680.
25. Sima AAF, Ristich H, Merry A, Kamijo M, Lattimer SA, Stevens MJ, Greene DA: Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat. J. Clin. Invest. 1996; 97:1900-1907.
26. Arduini A, Chiodi P, Bellucci A, Calvani M.: Abnormality of nerve conduction in diabetic neuropathy: is there a functional relationship with the carnitine system? Neurology 1996; 46:851.
27. Peripheral Nerve Society: Diabetic polyneuropathy in controlled clinical trials: consensus report of the Peripheral Nerve Society. Ann. Neurol. 1995; 38:478-482.
28. Dyck PJ, Karnes JL, Daube J, O'Brien P, Service FJ: Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 1985; 108: 861-880.
29. Vital A, Vital C, Brechenmacher C, Serise JM, Callen S, Nicolau H, Videau J: Quantitative, histological and ultrastructural studies of peripheral nerve in arteriosclerotic non-diabetic patients. Clin. Neuropathol. 1986; 5: 224-229.
30. Pande S, Caramancion MN: A simple radioisotopic assay of acetylcarnitine and acetyl-CoA at picomolar levels. Anal. Biochem. 1981; 112:30-38.
31. Pace JA, Wannemaher RW Jr, Neufeld HA: Improved radiochemical assay for carnitine and its derivatives in plasma and tissue extracts. Clin. Chem. 1978; 24:32-35.
32. Dyck PJ, Lais A, Karnes JL, O'Brien P, Rizza R: Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann. Neurol. 1986; 19:425-439.
33. DeSousa C, Leung NWY, Chalmers RA, Peters TJ: Free and total carnitine and acylcarnitine content of plasma, urine, liver and muscle of alcoholics Clin. Sci. 1988; 75: 437-440.
34. Hoppel CL, Genuth SM: Carnitine metabolism in normal weight and obese human subjects during fasting. Am. J. Physiol. 1980; 23:E409-E415.
35. Hoppel CL, Floyd R, Albers L, Turkaly: Pharmacokinetics and bioavailability of L-carnitine in normal humans. Clin. Res. 1990; 38:833A.
36. Taglialatela G, Angelucci L, Ramacci MT, Werrbach-Perez K, Jackson GR, Perez-Polo R: Stimulation of nerve growth factor receptors in PC12 by acetyl-L-carnitine. Biochem. Pharmacol. 1992; 44:557.
37. Kerner J, Bieber LL: The effect of electrical stimulation, fasting and anesthesia on the carnitine(s) and acyl-carnitines of rat white and red skeletal muscle fibres. Comp. Biochem. Physiol. 1983;75B(2):311-316.